Skip to Content

Join the 'Cangrelor' group to help and get support from people like you.

Cangrelor News

Anti-Clotting Drug Approved For Angioplasty

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – Kengreal (cangrelor) has been approved by the U.S. Food and Drug Administration to prevent blood clots from forming during angioplasty. Angioplasty involves inflating a balloon inside a clogged artery to improve blood flow. This is typically followed by insertion of a stent, a small mesh tube designed to keep the artery open. Some 500,000 people in the United States have the procedure – medically called percutaneous coronary intervention – annually, the FDA said in a news release. Formation of a blood clot during the procedure could lead to heart attack. As with any anti-clotting drug, life-threatening bleeding is a potential side effect, the agency noted. In clinical trials, Kengreal was compared to the anti-clotting drug Plavix (clopidogrel) among more than 10,000 participants. Cases of serious bleeding, while still rare, were more common among users who ... Read more

Related support groups: Magnetic Resonance Angiography, Cangrelor, Intra-arterial Digital Subtraction Angiography, Peripheral Angiography, Kengreal, High Risk Percutaneous Transluminal Angioplasty, Digital Subtraction Angiography

FDA Approves Antiplatelet Agent Kengreal (cangrelor) as Adjunct to Percutaneous Coronary Intervention

Posted 22 Jun 2015 by Drugs.com

June 22, 2015 – The U.S. Food and Drug Administration today approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart. It is approved for adult patients undergoing percutaneous coronary intervention (PCI), a procedure used to open a blocked or narrowed coronary artery to improve blood flow to the heart muscle. According to the Centers for Disease Control and Prevention, PCI is performed on approximately 500,000 people in the United States each year. The coronary arteries are opened by inflating a balloon at the site of the narrowing, usually followed by placement of a small mesh tube, called a stent, to keep the artery open. By preventing platelets from accumulating, Kengreal reduces the risk of serious clotting complications related to the procedure, ... Read more

Related support groups: Percutaneous Coronary Intervention, Kengreal, Cangrelor

Ask a Question

Further Information

Related Condition Support Groups

Percutaneous Coronary Intervention

Related Drug Support Groups

Kengreal

Cangrelor Patient Information at Drugs.com